Thyrotropin releasing hormone (TRH) studies in patients with thyroid cancer.
D000230:Adenocarcinoma / Q000097:blood; D000368:Aged; D002277:Carcinoma / Q000097:blood; D005260:Female; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D007455:Iodine / Q000378:metabolism*; D007456:Iodine Isotopes; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011863:Radioimmunoassay; D013961:Thyroid Gland / Q000378:metabolism*; D013964:Thyroid Neoplasms / Q000097:blood*; D013965:Thyroidectomy; D013972:Thyrotropin / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D013974:Thyroxine / Q000097:blood*; D014284:Triiodothyronine / Q000032:analysis
D007456:Iodine Isotopes; D014284:Triiodothyronine; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D007455:Iodine; D013974:Thyroxine